RDIF and Hetero agree to produce over 100 million doses of the Sputnik V vaccine in India
Moscow, Russia/Hyderabad, India, November 27, 2020 (GPN) –The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Hetero, one of India’s leading generic pharmaceutical companies (through its biologics arm “Hetero Biopharma”) have agreed to…









